Dr Salari definitely has their attention from his trial in europe & he holds the patent, so they will have to approach him for the patient rights after the trials
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.